# Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

> **NCT04191447** · PHASE3 · UNKNOWN · sponsor: **EMS** · enrollment: 134 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Flamboyant 200/12
- **DRUG:** Budesonide / Formoterol 400/12
- **OTHER:** Flamboyant 200/12 Placebo
- **OTHER:** Budesonide / Formoterol 400/12 Placebo

## Key facts

- **NCT ID:** NCT04191447
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-22
- **Primary completion:** 2023-07
- **Final completion:** 2023-10
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04191447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04191447, "Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04191447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*